Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Similar Burden of Type 2 Diabetes Among Adult Patients With Sickle Cell Disease Relative to African Americans in the U.S. Population: A Six-Year Population-Based Cohort Analysis
source: British Journal of Haematology
year: 2019
authors: Zhou J, Han J, Nutescu EA, Galanter WL, Walton SM, Gordeuk VR, Saraf SL, Calip GS
summary/abstract:Conflicting evidence exists on the epidemiology of type 2 diabetes mellitus (T2DM) among patients with sickle cell disease (SCD). This study measured the prevalence, incidence and clinical outcomes associated with T2DM in a large US population of commercially-insured adults aged >=20 years with SCD between 2009 and 2014. Among 7070 patients with SCD, the mean age (median) was 39 (37) years and 60•8% were female. The standardized prevalence of T2DM among patients with SCD showed a modest increase, from 15•7% to 16•5% (P trend = 0•026), and was comparable to African-American respondents to the National Health and Nutrition Examination Survey (18•2%). Over 17 024 person-years, the crude incidence rate for T2DM was 25•4 per 1000 person-years. Incident T2DM was associated with comorbid hypertension (hazard ratio [HR] = 1•45, 95% confidence interval [CI] 1•14-1•83), and dyslipidaemia (HR = 1•43, 95%CI 1•04-1•96). Compared to SCD patients without T2DM, more SCD patients with T2DM had diagnoses of nephropathy (28•0% vs. 9•5%; P < 0•001), neuropathy (17•7% vs. 5•2%; P < 0•001) and stroke (24•1% vs. 9•2%; P < 0•001). Prevalence of T2DM in SCD patients is similar to the general African American population with an increasing trend in recent years. These trends support routine screening for T2DM in aging patients with SCD, especially those with comorbid hypertension and/or dyslipidaemia.
organization: University of Illinois at Chicago, USA; Fred Hutchinson Cancer Research Center, USADOI: 10.1111/bjh.15773
read more
+myBinderRelated Content
-
University of Maryland Medical CenterThe University of Maryland Medical Cente...
-
Benign Hematologic Disorders in Children, an Issue of Pediatric Clinics of North America, Volume 65-3This issue will provide a current update...
-
Patrick C. Hines, MD, PhDPatrick C. Hines, MD, PhD is an experien...
-
ATS Releases Guidelines for Home Oxygen Therapy in Children With Sickle Cell DiseaseThe American Thoracic Society (ATS) rele...
-
Endari: A Treatment Option for Sickle Cell DiseaseEndari is an amino acid, approved by Foo...
-
Z. Jim Wang, PhDDr. Wang is a professor of pharmacology ...
-
T-Boz: Vote on Tuesday Like Your Health Depends on ItAs a mother, I know that I have a respon...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.